SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 405 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,575,422 | +5.9% | 557,461 | +0.0% | 0.02% | +11.8% |
| Q2 2023 | $63,831,501 | +74.1% | 557,383 | +109.6% | 0.02% | +70.0% |
| Q1 2023 | $36,654,648 | -84.4% | 265,941 | -89.5% | 0.01% | -81.8% |
| Q3 2021 | $235,102,000 | -36.3% | 2,542,191 | -46.5% | 0.06% | -36.0% |
| Q2 2021 | $369,325,000 | -38.3% | 4,750,769 | -40.8% | 0.09% | -41.1% |
| Q1 2021 | $598,241,000 | -54.6% | 8,026,903 | +3.8% | 0.15% | -57.3% |
| Q4 2020 | $1,319,041,000 | +40.0% | 7,736,748 | +15.3% | 0.34% | +20.8% |
| Q3 2020 | $942,473,000 | +24.9% | 6,711,324 | +42.7% | 0.28% | +18.4% |
| Q2 2020 | $754,349,000 | +99.0% | 4,704,681 | +21.4% | 0.24% | +60.4% |
| Q1 2020 | $379,048,000 | +21.9% | 3,874,958 | +60.8% | 0.15% | +60.2% |
| Q4 2019 | $310,864,000 | – | 2,409,053 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |